Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Headache, Illness, Inappropriate schedule of product administration
Clinical narrative: Muscle aches; Headache; Chills; Nausea; vomiting; inappropriate schedule of vaccine administered; Shortness of breath; Diarrhea; Loss of smell; physically weak; it took her lots of energy to do simple tasks; congested / Nasal congestion; a lot of pressure in her sinuses; completely lost her sense of taste and smell; completely lost her sense of taste and smell; runny nose; cough; really bad sore throat; felt overall sick; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle aches), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (vomiting) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039M2014 and 02SJ20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (really bad sore throat), COUGH (cough) and ILLNESS (felt overall sick). On 22-Apr-2021, the patient experienced SENSORY LOSS (completely lost her sense of taste and smell), AGEUSIA (completely lost her sense of taste and smell), RHINORRHOEA (runny nose), ASTHENIA (physically weak), ASTHENIA (it took her lots of energy to do simple tasks), NASAL CONGESTION (congested / Nasal congestion) and PARANASAL SINUS DISCOMFORT (a lot of pressure in her sinuses). On an unknown date, the patient experienced MYALGIA (Muscle aches), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea), VOMITING (vomiting), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered), DYSPNOEA (Shortness of breath), DIARRHOEA (Diarrhea) and ANOSMIA (Loss of smell). At the time of the report, MYALGIA (Muscle aches), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea), VOMITING (vomiting), SENSORY LOSS (completely lost her sense of taste and smell), AGEUSIA (completely lost her sense of taste and smell), RHINORRHOEA (runny nose), COUGH (cough), ASTHENIA (physically weak), ASTHENIA (it took her lots of energy to do simple tasks), NASAL CONGESTION (congested / Nasal congestion), PARANASAL SINUS DISCOMFORT (a lot of pressure in her sinuses), ILLNESS (felt overall sick), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered), DYSPNOEA (Shortness of breath), DIARRHOEA (Diarrhea) and ANOSMIA (Loss of smell) outcome was unknown and OROPHARYNGEAL PAIN (really bad sore throat) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, SARS-CoV-2 test: tested positive Positive. On 23-Apr-2021, SARS-CoV-2 test: tested positive (Positive) Tested positive for COVID for the second time.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment drugs were reported.   This case was linked to MOD-2021-089379 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: No specific follow-up information recorded.